ArticleThe World Allergy Organization journal2026
Associations between dual use of combustible cigarettes and electronic nicotine delivery systems and allergic rhinitis: An analysis of KNHANES data.
Article in The World Allergy Organization journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The dual use of combustible cigarettes (CC) and electronic nicotine delivery systems (ENDS) is a rapidly growing public health concern, yet its synergistic impact on allergic rhinitis (AR) remains poorly understood. Previous studies have reported inconsistent associations between smoking and AR, often failing to account for different tobacco product combinations and the temporal sequence of smoking initiation. Objective: To analyze the association between diverse smoking behaviors-including exclusive CC use, exclusive ENDS use, and dual use-and the odds of AR diagnosis among Korean adults. Methods: We analyzed data from 18,781 adults from the 2019-2022 KNHANES. Multivariable survey-weighted logistic regression estimated adjusted odds ratios (AOR) across 5 patterns: never, former, exclusive CC, exclusive ENDS, and dual users. Sensitivity analyses were conducted to establish temporal precedence by restricting the sample to those who initiated smoking prior to their AR diagnosis. Further stratified analyses were performed based on smoking intensity (Cigarettes Per Day [CPD]). Results: The overall weighted prevalence of AR was 17.77%. In the primary model, exclusive CC smokers showed lower odds of AR (AOR = 0.691; 95% CI = 0.562-0.850), which decreased further to 0.519 (p < 0.001) upon temporal validation. While the primary model showed higher odds for former smokers (AOR = 1.193), the validated subset revealed a significant inverse association (AOR = 0.836, p = 0.018), identifying a "sick quitter" effect. Conversely, dual use of CC and vapes was significantly associated with higher AR odds (AOR = 1.543; 95% CI = 1.067-2.233, p = 0.021). This risk peaked among moderate smokers using vapes (AOR = 2.222, p = 0.029) and heavy smokers using heated tobacco products (AOR = 2.374; 95% CI = 1.059-5.322, p = 0.036). Conclusion: Our findings reveal a distinct contrast between exclusive smoking and dual use. While exclusive CC smoking exhibits an inverse association likely driven by nicotine-mediated symptom masking, dual use presents a unique synergistic risk. This suggests that combined exposure to multiple tobacco products may exacerbate mucosal inflammation and barrier dysfunction, overriding any suppressive effects of nicotine.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.